Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadruple vs Tailored Therapy for H. Pylori
NCT04621487Completed
- Sponsor
- University of Split School of Medicine
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amoxicillin, clarithromycin, metronidazole and pantoprazole in Helicobacter pylori infection (2 arms), sponsored by University of Split School of Medicine. Primary endpoint: Helicobacter pylori Eradication Rate. Started Jan 2019; status: completed.
02
Drugs
amoxicillinclarithromycinmetronidazolepantoprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04621487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04621487.